FDA Approves First Lupus Treatment in Pediatric Patients – BioPharm International

[ad_1]
FDA Approves First Lupus Treatment in Pediatric Patients BioPharm International

The agency has approved the intravenous infusion of Benlysta (belimumab) for the treatment of children with systemic lupus erythematosus.

[ad_2]
Source link